Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion type Assertion NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_head.
- NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion description "[However, when determining merlin and ezrin in ovarian carcinoma cells, we have observed that both merlin and ezrin could be over-expressed simultaneously in some ovarian cancer (OVCA) cell lines and OVCA ascites cells, suggesting that merlin could be an oncoprotein rather than a tumor suppressor protein in certain OVCA cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_provenance.
- NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion evidence source_evidence_literature NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_provenance.
- NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion SIO_000772 16824698 NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_provenance.
- NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion wasDerivedFrom befree-2016 NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_provenance.
- NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_assertion wasGeneratedBy ECO_0000203 NP558584.RAfJrpgH5xF5m0RzM64mBdI_5cujMrRmsrDArMxlxGc-A130_provenance.